Home/Filings/4/0001179110-05-016723
4//SEC Filing

ROSSETTOS NICHOLAS J 4

Accession 0001179110-05-016723

CIK 0001001316other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:40 PM ET

Size

16.4 KB

Accession

0001179110-05-016723

Insider Transaction Report

Form 4
Period: 2005-01-11
ROSSETTOS NICHOLAS J
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2005-01-11+50,00050,000 total
    Exercise: $1.00Exp: 2015-01-11Common Stock (50,000 underlying)
Holdings
  • Stock Options

    Exercise: $20.94Exp: 2010-04-12Common Stock (10,000 underlying)
    10,000
  • Stock Options

    Exercise: $1.00From: 2002-03-28Exp: 2012-03-28Common Stock (25,000 underlying)
    25,000
  • Stock Options

    Exercise: $1.65Exp: 2014-01-28Common Stock (150,000 underlying)
    150,000
  • Stock Options

    Exercise: $0.40Exp: 2013-02-24Common Stock (292,030 underlying)
    292,030
Footnotes (8)
  • [F1](Right to buy)
  • [F2]Currently exercisable.
  • [F3]2,500 shares vest on each of 2/20/01, 2/20/02, 2/20/03 and 2/20/04.
  • [F4]2,500 shares vest on each of 2/19/02, 2/19/03, 2/19/04 and 2/19/05.
  • [F5]146,015 shares are currently vested; 146,015 shares vest on 2/24/05.
  • [F6]Option vests on the earlier of FDA approval or Catarex or 2/19/07.
  • [F7]50,000 shares vest on each of 1/28/04, 1/28/05 and 1/28/06.
  • [F8]25,000 shares vest on each of 1/3/06 and 1/3/07.

Issuer

MANHATTAN PHARMACEUTICALS INC

CIK 0001001316

Entity typeother

Related Parties

1
  • filerCIK 0001167450

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:40 PM ET
Size
16.4 KB